Sigma Svi Bio Solutions Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 04-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 04-07-2024
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.40 Cr
as on 04-07-2024
- Revenue -95.66%
(FY 2021)
- Profit -96.55%
(FY 2021)
- Ebitda 87.80%
(FY 2021)
- Net Worth 2.38%
(FY 2021)
- Total Assets -1.54%
(FY 2021)
About Sigma Svi Bio Solutions
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹4.00 M.
Chaitanya Kaushik, Kusum Kaushik, and Kinni Kaushik serve as directors at the Company.
- CIN/LLPIN
U51909DL2008PTC185060
- Company No.
185060
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Central Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Sigma Svi Bio Solutions Private Limited offer?
Sigma Svi Bio Solutions Private Limited offers a wide range of products and services, including Laboratory Centrifuge, Microcentrifuge, Certification Services, Six Sigma Consultants, Thermostat, Pathology Lab Equipments, Refrigerated Centrifuge, Bulk Handling Equipment, Fluid Handling Equipment.
Who are the key members and board of directors at Sigma Svi Bio Solutions?
Board Members(3)
Financial Performance and Corporate Structure Insights of Sigma Svi Bio Solutions.
Sigma Svi Bio Solutions Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 95.66% decrease. The company also saw a substantial fall in profitability, with a 96.55% decrease in profit. The company's net worth moved up by a moderate rise of 2.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sigma Svi Bio Solutions?
In 2021, Sigma Svi Bio Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sv Instruments Analytica Private Limited
Active 31 years 15 daysChaitanya Kaushik, Kusum Kaushik and 1 more are mutual person
Daihan Labtech India Private Limited
Active 15 years 9 monthsChaitanya Kaushik and Kinni Kaushik are mutual person
Svi Research & Training Private Limited
Active 25 years 1 monthChaitanya Kaushik, Kusum Kaushik and 1 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 27 Jun 2012 | ₹4.00 M | Open |
How Many Employees Work at Sigma Svi Bio Solutions?
Unlock and access historical data on people associated with Sigma Svi Bio Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Mar 29, 2010, Sigma Svi Bio Solutions has raised a total of ₹ 7 M, with the most recent deal valued at ₹ 4 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.